Middlemost, Shirley

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3,163

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 638

A case for early surgery in native left-sided endocarditis complicated by heart failure: Results in 203 patients

Middlemost, S., Wisenbaugh, T., Meyerowitz, C., Teeger, S., Essop, R., Skoularigis, J., Cronje, S., & Sareli, P. (1991) · Journal of the American College of Cardiology

Infective Endocarditis Diagnosis and ManagementCardiac Valve Diseases and Treatments

Cited by 141